Renalytix Plc (NASDAQ:RNLX) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Renalytix Conference Call to review Second Quarter and First Half Fiscal Year 2023 Financial Results.
Source: insidermonkey.com
📰 Peter Denardo News
Page 4 - Peter Denardo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Peter Denardo. Real-time updates on events, politics, business and more.
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
LONDON and SALT LAKE CITY, March 30, 2023 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive... | March 30, 2023
Source: marketscreener.com
Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Sera Prognostics Conference Call to Review Fourth Quarter and Fiscal Year 2022 results. At this time, all participants are in listen-only mode.
Source: insidermonkey.com
Investegate |Renalytix PLC Announcements | Renalytix PLC: Business Update
Investegate announcements from Renalytix PLC, Business Update - Replacement
Source: investegate.co.uk
Standard BioTools Inc. (NASDAQ:LAB) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Standard BioTools Inc. Fourth Quarter and Full Year 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
United States San Francisco Peter Denardo Michael Egholm Most Valuable Hotel Companies Standard Biotools Inc
Source: insidermonkey.com
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
United States Salt Lake City Gregoryc Critchfield Peter Denardo Exchange Commission On Sera Prognostics Inc
Source: prnewswire.com
Standard BioTools Reports Fourth Quarter and Full Year 2022
Fourth quarter 2022 GAAP revenues of $27.0 million; Core product and service revenues of $26.8 million, representing 8.3% sequential growth; Full year GAAP...
United States Peter Denardo Michael Egholm Standard Biotools Inc Exchange Commission American Association For Cancer Research
Source: globenewswire.com
Investegate |Renalytix PLC Announcements | Renalytix PLC: RENX to Participate in the BTIG MedTech Conference
Investegate announcements from Renalytix PLC, RENX to Participate in the BTIG MedTech Conference
Source: investegate.co.uk
Investegate |Renalytix PLC Announcements | Renalytix PLC: Renalytix announces a c.$20.3m private placement
Investegate announcements from Renalytix PLC, Renalytix announces a c.$20.3m private placement
United Kingdom United States City Of Nicholas Moore Alex Christopher Mills Paul Mcmanus Lianne Applegarth
Source: investegate.co.uk
Renalytix Plc (NASDAQ:RNLX) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Renalytix Conference Call to review First Quarter Fiscal 2023 Financial Results. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com